David Jagielski (Abbott Laboratories): When you're looking for ... Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company ...

The Q2 earnings season is underway in full swing; till now, companies from various sectors have already declared their Q2 results. Today there will be 146 companies that are scheduled to post their ...

NHPC, Lupin, Mahindra & Mahindra, Rail Vikas Nigam Ltd., and Trent are set to release their Q2 earnings today, with strong ...

In addition to the above companies, the ones that will be declaring their Q2 results on Nov. 7 include NHPC, Aditya Birla Fashion and Retail, Bajaj Electricals and Cummins India.

Abbott Laboratories showcases robust financial performance with a notable increase in net earnings. Strategic acquisitions and product launches strengthen the company's market presence.

CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...

So on that note, Abbott Laboratories (NYSE:ABT) looks quite promising in regards to its trends of return on capital. What Is Return On Capital Employed (ROCE)? Just to clarify if you're unsure ...

In the last three months, 15 analysts have published ratings on Abbott Laboratories (NYSE:ABT), offering a diverse range of perspectives from bullish to bearish. The table below summarizes their ...

Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...

CNBC's Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that's been weighed down by ongoing litigation for several months. Abbott was cleared Thursday night of ...

On Monday, Barclays maintained an Overweight rating on Abbott Labs (NYSE:ABT) shares and increased the price target to $149 from $143. The adjustment follows a favorable verdict for Abbott in a ...